intismeran autogene

On August 15, Anthropic CEO Dario Amodei argued that AI companies will earn trust by curing diseases, and the past week showcased advances in AI-driven medicine, including Moderna and Merck's INTerpat…

Moderna and Merck's experimental mRNA cancer vaccine intismeran autogene met its primary endpoint of recurrence-free survival and a key secondary endpoint in a Phase 3 trial of 1,137 patients with res…